Skip to main content
Top
Published in: BMC Pulmonary Medicine 1/2021

Open Access 01-12-2021 | Patent Ductus Arteriosus | Research Article

The effects of ductal size on the severity of pulmonary hypertension in children with patent ductus arteriosus (PDA): a multi-center study

Authors: Josephat M. Chinawa, Bartholomew F. Chukwu, Awoere T. Chinawa, Chika O. Duru

Published in: BMC Pulmonary Medicine | Issue 1/2021

Login to get access

Abstract

Introduction

Patent ductus arteriosus (PDA) is a common acyanotic heart disease that presents with variable symptoms.

Objectives

This study is therefore aimed at determining the relationship between gender, age, and size of PDA and pulmonary hypertension. This study also seeks to determine the prevalence of elevated pulmonary artery systolic pressure in children with PDA.

Patients and methods

A descriptive study of children with patent ductus arteriosus was carried out from 2016 to 2020 in three institutions. The data were analysed with the IBM SPSS statistics for windows, version 20 (IBM Corp, Chicago)

Result

The mean ductal size was 3.78 (2.39) mm, with a minimum of 1.0 mm and a maximum size of 10.0 mm. The mean ductal size for males, 4.02 (2.53) mm was comparable with that of the females, 3.61 (2.28) mm (Student T-test = 0.8, 0.4). The mean pulmonary artery systolic pressure (PASP) of the patients was 43.36 (24.46) mmHg. Also the mean PASP was comparable among the males and the females, 48.37 (26.69) mmHg versus 39.63 (22.16) mmHg (Student T-test = 1.81, p = 0.07). There was no correlation between age and PASP (correlation coefficient = 0.009, p = 0.92). Sixty point two percent (60.2%) (62/103) of children with PDA had pulmonary hypertension. The proportion of males with pulmonary hypertension, 48.39% (30/62) was comparable with that of the females, 51.61% (32/62) (Chi2 = 2.05, p = 0.15) and females are 1.8 times more likely to have pulmonary hypertension as males (odds ratio 1.81, 95% CI 0.8–4.1). There was a positive correlation between ductal size and PASP (Pearson correlation coefficient = 0.26, p value = 0.007). Those with moderate and large sized duct tend to have moderate and severe pulmonary hypertension respectively and this is statistically significant. Chi2 = 17.85, p = 0.007

Conclusion

The prevalence of pulmonary hypertension in children with PDA is 60.2%. Moderate and large size duct presents with moderate and severe pulmonary hypertension respectively. Females are 1.8 times more likely to have pulmonary hypertension than the males.
Appendix
Available only for authorised users
Literature
1.
go back to reference Kaemmerer H, Meisner H, Hess J, Perloff JK. Surgical treatment of patent ductus arteriosus: a new historical perspective. Am J Cardiol. 2004;94:1153–4.CrossRef Kaemmerer H, Meisner H, Hess J, Perloff JK. Surgical treatment of patent ductus arteriosus: a new historical perspective. Am J Cardiol. 2004;94:1153–4.CrossRef
2.
go back to reference Chaudhury M, Sohel MA, Muhammad KH, Abed HK, Lima AS, Ashraf US. Validity of estimation of pulmonary artery pressure using continuous wave Doppler echocardiography in patient with patent ductus arteriosus (PDA). Univ Heart J. 2011;7:10–2. Chaudhury M, Sohel MA, Muhammad KH, Abed HK, Lima AS, Ashraf US. Validity of estimation of pulmonary artery pressure using continuous wave Doppler echocardiography in patient with patent ductus arteriosus (PDA). Univ Heart J. 2011;7:10–2.
3.
go back to reference Arlettaz R. Echocardiographic evaluation of patent ductus arteriosus in preterm infants. Front Pediatr. 2017;5:147.CrossRef Arlettaz R. Echocardiographic evaluation of patent ductus arteriosus in preterm infants. Front Pediatr. 2017;5:147.CrossRef
4.
go back to reference Philip R, Nathaniel Johnson J, Naik R, Kimura D, Boston U, Chilakala S, et al. Effect of patent ductus arteriosus on pulmonary vascular disease. Congenit Heart Dis. 2019;14:37–41.CrossRef Philip R, Nathaniel Johnson J, Naik R, Kimura D, Boston U, Chilakala S, et al. Effect of patent ductus arteriosus on pulmonary vascular disease. Congenit Heart Dis. 2019;14:37–41.CrossRef
5.
go back to reference Condo M, Evans N, Bellu R, Kluckow M. Echocardiographic assessment of ductal significance: retrospective comparison of two methods. Arch Dis Child Fetal Neonatal Ed. 2012;97:35–8.CrossRef Condo M, Evans N, Bellu R, Kluckow M. Echocardiographic assessment of ductal significance: retrospective comparison of two methods. Arch Dis Child Fetal Neonatal Ed. 2012;97:35–8.CrossRef
6.
go back to reference Schneider DJ, Moore JW. Patent ductus arteriosus. Circulation. 2006;114:1873–82.CrossRef Schneider DJ, Moore JW. Patent ductus arteriosus. Circulation. 2006;114:1873–82.CrossRef
7.
go back to reference Tharakan J, Venkateshwaran S. Large patent ductus arteriosus: to close or not to close. Ann Pediatr Cardiol. 2012;5:141–4.CrossRef Tharakan J, Venkateshwaran S. Large patent ductus arteriosus: to close or not to close. Ann Pediatr Cardiol. 2012;5:141–4.CrossRef
8.
go back to reference Global, regional, and national burden of congenital heart disease, 1990–2017: a systematic analysis for the Global Burden of Disease Study. 2020; 4:185–200. Global, regional, and national burden of congenital heart disease, 1990–2017: a systematic analysis for the Global Burden of Disease Study. 2020; 4:185–200.
9.
go back to reference van Laere D, van Overmeire B, Gupta S, El-Khuffash A, Savoia M, McNamara PJ, Schwarz CE, de Boode WP. European Special Interest Group ‘Neonatologist Performed Echocardiography’ (NPE). Application of NPE in the assessment of a patent ductus arteriosus. Pediatr Res. 2018;84:46–56.CrossRef van Laere D, van Overmeire B, Gupta S, El-Khuffash A, Savoia M, McNamara PJ, Schwarz CE, de Boode WP. European Special Interest Group ‘Neonatologist Performed Echocardiography’ (NPE). Application of NPE in the assessment of a patent ductus arteriosus. Pediatr Res. 2018;84:46–56.CrossRef
11.
go back to reference Vaidyanathan B, Nair SB, Sundaram KR, Babu UK, Shivaprakasha K, Rao SG, et al. Malnutrition in children with congenital heart disease (CHD) determinants and short term impact of corrective intervention. Indian Pediatr. 2008;45:541–6.PubMed Vaidyanathan B, Nair SB, Sundaram KR, Babu UK, Shivaprakasha K, Rao SG, et al. Malnutrition in children with congenital heart disease (CHD) determinants and short term impact of corrective intervention. Indian Pediatr. 2008;45:541–6.PubMed
12.
go back to reference Chugh R, Salem MM. Echocardiography for patent ductus arteriosus including closure in adults. Echocardiography. 2015;32:125–39.CrossRef Chugh R, Salem MM. Echocardiography for patent ductus arteriosus including closure in adults. Echocardiography. 2015;32:125–39.CrossRef
13.
go back to reference McNamara PJ, Sehgal A. Towards rational management of the patent ductus arteriosus: the need for disease staging. Arch Dis Child Fetal Neonatal Ed. 2007;92:424–7.CrossRef McNamara PJ, Sehgal A. Towards rational management of the patent ductus arteriosus: the need for disease staging. Arch Dis Child Fetal Neonatal Ed. 2007;92:424–7.CrossRef
14.
go back to reference Simonneau G, Hoeper MM. The revised definition of pulmonary hypertension: exploring the impact on patient management. Eur Heart J Suppl. 2019;21:4–8.CrossRef Simonneau G, Hoeper MM. The revised definition of pulmonary hypertension: exploring the impact on patient management. Eur Heart J Suppl. 2019;21:4–8.CrossRef
17.
go back to reference Kang C, Zhao E, Zhou Y, et al. Dynamic changes of pulmonary artery systolic pressureand ductus arteriosus in human new-borns from birth to 72 hours of age. Medicine (Baltimore). 2016;95:2599.CrossRef Kang C, Zhao E, Zhou Y, et al. Dynamic changes of pulmonary artery systolic pressureand ductus arteriosus in human new-borns from birth to 72 hours of age. Medicine (Baltimore). 2016;95:2599.CrossRef
19.
go back to reference Fortescue EB, Lock JE, Galvin T, McElhinney DB. To close or not to close: the very small patent ductus arteriosus. Congenit Heart Dis. 2010;5(4):354–65.CrossRef Fortescue EB, Lock JE, Galvin T, McElhinney DB. To close or not to close: the very small patent ductus arteriosus. Congenit Heart Dis. 2010;5(4):354–65.CrossRef
20.
go back to reference Tripathi A, Black GB, Park YM, Jerrell JM. Prevalence and management of patent ductus arteriosus in a paediatric medical cohort. Clin Cardiol. 2013;36:502–6.CrossRef Tripathi A, Black GB, Park YM, Jerrell JM. Prevalence and management of patent ductus arteriosus in a paediatric medical cohort. Clin Cardiol. 2013;36:502–6.CrossRef
21.
go back to reference Weijerman ME, van Furth AM, van der Mooren MD, van Weissenbruch MM, Rammeloo L, Broers CJ, Gemke RJ. Prevalence of congenital heart defects and persistent pulmonary hypertension of the neonate with Down syndrome. Eur J Pediatr. 2010;169:1195–9.CrossRef Weijerman ME, van Furth AM, van der Mooren MD, van Weissenbruch MM, Rammeloo L, Broers CJ, Gemke RJ. Prevalence of congenital heart defects and persistent pulmonary hypertension of the neonate with Down syndrome. Eur J Pediatr. 2010;169:1195–9.CrossRef
22.
go back to reference Niu MC, Mallory GB, Justino H, Ruiz FE, Petit CJ. Treatment of severe pulmonary hypertension in the setting of the large patent ductus arteriosus. Pediatrics. 2013;131:1643–9.CrossRef Niu MC, Mallory GB, Justino H, Ruiz FE, Petit CJ. Treatment of severe pulmonary hypertension in the setting of the large patent ductus arteriosus. Pediatrics. 2013;131:1643–9.CrossRef
23.
go back to reference Berra G, Noble S, Soccal PM, Beghetti M, Lador F. Pulmonary hypertension in the elderly: a different disease? Breathe (Sheff). 2016;12:43–9.CrossRef Berra G, Noble S, Soccal PM, Beghetti M, Lador F. Pulmonary hypertension in the elderly: a different disease? Breathe (Sheff). 2016;12:43–9.CrossRef
24.
go back to reference Peacock AJ, Murphy NF, McMurray JJ, Caballero L, Stewart S. An epidemiological study of pulmonary arterial hypertension. Eur Respir J. 2007;30:104–9.CrossRef Peacock AJ, Murphy NF, McMurray JJ, Caballero L, Stewart S. An epidemiological study of pulmonary arterial hypertension. Eur Respir J. 2007;30:104–9.CrossRef
25.
go back to reference Ranjit P, Jason NJ, Ronak N, Dai K, Umar B, Sandeep C, Benjamin H, et al. Effect of patent ductus arteriosus on pulmonary vascular disease. Congenit Heart Dis. 2019;14:37–41.CrossRef Ranjit P, Jason NJ, Ronak N, Dai K, Umar B, Sandeep C, Benjamin H, et al. Effect of patent ductus arteriosus on pulmonary vascular disease. Congenit Heart Dis. 2019;14:37–41.CrossRef
26.
go back to reference Sook KY, Cheong JM, Young AY, Jae YL, In KS. Echocardiographic assessment of patent ductus arteriosus in very low birthweight infants over time: prospective observational study. J Maternal Fetal Neonatal Med. 2018;2:164–72. Sook KY, Cheong JM, Young AY, Jae YL, In KS. Echocardiographic assessment of patent ductus arteriosus in very low birthweight infants over time: prospective observational study. J Maternal Fetal Neonatal Med. 2018;2:164–72.
27.
go back to reference Sun M, Cheng C, Zhang R, et al. Zhonghua Xin Xue Guan Bing Za Zhi. Pulmonary hypertension after operation for congenital heart disease: Analysis of risk factors and management. J Thorac Cardiovasc Surg. 2014;42:396–9. Sun M, Cheng C, Zhang R, et al. Zhonghua Xin Xue Guan Bing Za Zhi. Pulmonary hypertension after operation for congenital heart disease: Analysis of risk factors and management. J Thorac Cardiovasc Surg. 2014;42:396–9.
29.
go back to reference Docherty CK, Harvey KY, Mair KM, Griffin S, Denver N, MacLean MR. The role of sex in the pathophysiology of pulmonary hypertension. Adv Exp Med Biol. 2018;1065:511–28.CrossRef Docherty CK, Harvey KY, Mair KM, Griffin S, Denver N, MacLean MR. The role of sex in the pathophysiology of pulmonary hypertension. Adv Exp Med Biol. 2018;1065:511–28.CrossRef
30.
go back to reference Shahnaz P, Nazanin F, Deepak S, Sirous C, Farhad B. Prevalence and risk factors associated with the patency of ductus arteriosus in premature neonates: a prospective observational study from Iran. J Matern Fetal Neonatal Med. 2017;30(12):1460–4.CrossRef Shahnaz P, Nazanin F, Deepak S, Sirous C, Farhad B. Prevalence and risk factors associated with the patency of ductus arteriosus in premature neonates: a prospective observational study from Iran. J Matern Fetal Neonatal Med. 2017;30(12):1460–4.CrossRef
31.
go back to reference Hagau N, Culcitchi C. Nutritional support in children with congenital heart disease. Nutr Ther Metab. 2010;28:172–84. Hagau N, Culcitchi C. Nutritional support in children with congenital heart disease. Nutr Ther Metab. 2010;28:172–84.
33.
go back to reference Evans JD, Girerd B, Montani D, Wang XJ, Galiè N, Austin ED, Elliott G, Asano K, Grünig E, et al. BMPR2 mutations and survival in pulmonary arterial hypertension: an individual participant data meta-analysis. Lancet Respir Med. 2016;4:129–37.CrossRef Evans JD, Girerd B, Montani D, Wang XJ, Galiè N, Austin ED, Elliott G, Asano K, Grünig E, et al. BMPR2 mutations and survival in pulmonary arterial hypertension: an individual participant data meta-analysis. Lancet Respir Med. 2016;4:129–37.CrossRef
34.
go back to reference Austin ED, Hamid R, Hemnes AR, Loyd JE, Blackwell T, Yu C, Phillips Iii JA, Gaddipati R, Gladson S, Gu E, West J, Lane KB. BMPR2 expression is suppressed by signaling through the estrogen receptor. Biol Sex Differ. 2012;3:6.CrossRef Austin ED, Hamid R, Hemnes AR, Loyd JE, Blackwell T, Yu C, Phillips Iii JA, Gaddipati R, Gladson S, Gu E, West J, Lane KB. BMPR2 expression is suppressed by signaling through the estrogen receptor. Biol Sex Differ. 2012;3:6.CrossRef
35.
go back to reference Yan L, Cogan JD, Hedges LK, Nunley B, Hamid R, Austin ED. The Y chromosome regulates BMPR2 expression via SRY: a possible reason “why” fewer males develop pulmonary arterial hypertension. Am J Respir Crit Care Med. 2018;198:1581–3.CrossRef Yan L, Cogan JD, Hedges LK, Nunley B, Hamid R, Austin ED. The Y chromosome regulates BMPR2 expression via SRY: a possible reason “why” fewer males develop pulmonary arterial hypertension. Am J Respir Crit Care Med. 2018;198:1581–3.CrossRef
36.
go back to reference Foderaro A, Ventetuolo CE. Pulmonary arterial hypertension and the sex hormone paradox. Curr Hypertens Rep. 2016;18:84.CrossRef Foderaro A, Ventetuolo CE. Pulmonary arterial hypertension and the sex hormone paradox. Curr Hypertens Rep. 2016;18:84.CrossRef
Metadata
Title
The effects of ductal size on the severity of pulmonary hypertension in children with patent ductus arteriosus (PDA): a multi-center study
Authors
Josephat M. Chinawa
Bartholomew F. Chukwu
Awoere T. Chinawa
Chika O. Duru
Publication date
01-12-2021

Other articles of this Issue 1/2021

BMC Pulmonary Medicine 1/2021 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.